Cite
HARVARD Citation
Benchabane, S. et al. (2018). Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome. Immunopharmacology and immunotoxicology. pp. 126-133. [Online].